The new company combines Tahoe’s AI-powered target discovery engine with Alloy’s industry-leading ADC development capabilities to advance two first-in-class oncology programs built on deeply validated ...
Alloy Therapeutics and CDMO Wheeler Bio formed a nonexclusive, preferred service offering to advance potential new products from discovery to CMC development, GMP manufacturing, and clinical material ...
Tahoe Therapeutics and Alloy Therapeutics to Form Joint Venture and Develop First-in-Class Antibody-Drug Conjugates for Hard-to-Treat Cancers The new company combines Tahoe’s AI-powered target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results